SLPI and colorectal carcinoma: Among the top ten CAFs, antileukoproteinase (ALP) and vascular endothelial growth factor receptor 3 (VEGFR-3), are both known to regulate NF-κB signaling thereby affecting immune responses and growth of CRC [24, 25].